Dr. Larry Di Fabrizio, MD

Dr. Di Fabrizio practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Di Fabrizio's NPI, 1154393452, was assigned on February 2, 2006. Dr. Di Fabrizio graduated from WashU Medicine in 1984. Dr. Di Fabrizio holds New York license 175377.

Dr. Di Fabrizio's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Di Fabrizio also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Di Fabrizio's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Di Fabrizio is also affiliated with Tisch Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Di Fabrizio to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Di Fabrizio practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Di Fabrizio's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Di Fabrizio is board certified in sleep medicine by the American Board of Family Medicine. Dmand AI has Dr. Di Fabrizio's licenses on file in 2 states: New York and Connecticut.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis and pleural effusion among the conditions Dr. Di Fabrizio treats.

CMS data shows 3,398 Medicare services from Dr. Di Fabrizio across 8 procedure codes in 2024, for 703 Medicare patients. Medicare paid $266,100 for them.

CMS counts 703 Medicare patients who saw Dr. Di Fabrizio in 2024. The largest group is 75 to 84, with 311 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Di Fabrizio's median patient age at 72, with 52% women.

In 2024, Dr. Di Fabrizio wrote 4,336 Medicare Part D claims for 476 patients. 59% of them were for generic drugs. CMS names the drug for 3,938 of them, across 69 drugs with 11 or more claims each, at $846,180 in total drug cost. In 2023, CMS named 4,032 claims across 62 drugs.

Dr. Di Fabrizio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Di Fabrizio as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Di Fabrizio from 3 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $108.

Dmand AI lists 2 awards for Dr. Di Fabrizio, most recently CMS Stage 1 EHR in 2013.

Dr. Di Fabrizio graduated from WashU Medicine in 1984.

Dr. Di Fabrizio is in network with 16 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.